Syncom Formulations Fixes Record Date for 10% Dividend on Sep 23; AGM on Sep 30
Syncom Formulations has set September 23, 2026, as the record date for a 10% dividend (₹0.10 per share) for FY2025-26, subject to AGM approval. The 38th AGM will be held on September 30, 2026, via video conference. Shareholders can waive their dividend entitlement by September 26, 2026.
The announcement concerns a routine dividend declaration and AGM schedule. The dividend amount is nominal, and the information is standard for listed companies, thus having a low impact on the company's stock.
The announcement is a routine corporate action regarding dividend payment and AGM scheduling. While a dividend is generally positive, the amount is small and subject to approval, thus not strongly impacting sentiment.
Syncom Formulations (India) Limited has announced that the "Record Date" has been fixed as Wednesday, 23rd September, 2026. This date is for determining the entitlement of members for the payment of a dividend at the rate of 10%, amounting to ₹0.10 per equity share of ₹1 each, for the financial year 2025-26.
This dividend is subject to the approval of the members at the Company's upcoming 38th Annual General Meeting (AGM). Shareholders who do not wish to receive the dividend are requested to submit a duly filled Dividend Waiver Form by 26th September, 2026. The form is available on the Company's website, and completed forms can be sent to finance@sfil.in or the RTA at investor@ankitonline.com / compliance@ankitonline.com.
Furthermore, the 38th Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, 30th September, 2026, at 2:00 P.M. The AGM will be conducted through Video Conferencing (VC)/Other Audio-Visual Means (OAVM), in compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.